EYPT - EyePoint spikes after safety update on lead asset
2023-09-11 14:21:30 ET
More on EyePoint
- Seeking Alpha’s Quant Rating on EyePoint Pharmaceuticals
- Historical earnings data for EyePoint Pharmaceuticals
- Financial information for EyePoint Pharmaceuticals
- EyePoint: Well-Funded And Catalyst-Rich, But Not Without Risks
- EyePoint Pharmaceuticals, Inc. ( EYPT ) Q2 2023 Earnings Call Transcript
- EyePoint Pharmaceuticals misses top and bottom line estimates
For further details see:
EyePoint spikes after safety update on lead asset